Monthly Archives: February 2020
Brexit – What’s the impact on medicines and medical devices supplied in Australia?
The long-awaited Brexit is underway with the UK exiting the EU on 31 January 2020 A transition period is now in effect until the end of 2020 with the possibility for extension. Its status quo for Australia during the transition … Continue reading
Posted in Regulatory Services, TGA, Uncategorized
Tagged Brexit, GMP, Medical Device, Regafairs, Regulatory, TGA
Comments Off on Brexit – What’s the impact on medicines and medical devices supplied in Australia?
TGO 91 and TGO 92 – are your labels ready?
Following the 4-year transition period, the medicine labelling Therapeutic Goods Orders (TGOs), TGO 91 for prescription medicines and TGO 92 for non-prescription medicines, will become mandatory on 1 September 2020. Medicines that are released for supply on or after 1 September … Continue reading
Posted in Life Sciences Industry, Regulatory Services, TGA
Tagged Labels, Regulatory Services, TGA
Comments Off on TGO 91 and TGO 92 – are your labels ready?
